| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1012784409 |
| P356 | DOI | 10.1007/S00253-011-3557-Z |
| P932 | PMC publication ID | 3189412 |
| P698 | PubMed publication ID | 21904817 |
| P5875 | ResearchGate publication ID | 51636412 |
| P50 | author | Anthony Maxwell | Q37380949 |
| Frédéric Collin | Q59680862 | ||
| P2093 | author name string | Shantanu Karkare | |
| P2860 | cites work | DNA topoisomerases: structure, function, and mechanism | Q22065417 |
| Structure-activity relationships of aminocoumarin-type gyrase and topoisomerase IV inhibitors obtained by combinatorial biosynthesis | Q24542413 | ||
| Pentapeptide repeat proteins | Q24653739 | ||
| Glutamate racemase from Mycobacterium tuberculosis inhibits DNA gyrase by affecting its DNA-binding | Q24674283 | ||
| Structural basis of gate-DNA breakage and resealing by type II topoisomerases | Q27324504 | ||
| Dimerization of Escherichia coli DNA-gyrase B provides a structural mechanism for activating the ATPase catalytic center | Q27621859 | ||
| In vitro inhibition of bacterial DNA gyrase by cinodine, a glycocinnamoylspermidine antibiotic | Q39832834 | ||
| Plasmid RK2 toxin protein ParE: purification and interaction with the ParD antitoxin protein | Q39840497 | ||
| Mechanism of action of cinodine, a glycocinnamoylspermidine antibiotic | Q39855825 | ||
| Biological characterization of cyclothialidine, a new DNA gyrase inhibitor | Q39883723 | ||
| Mutations in DNA gyrase result in novobiocin resistance in halophilic archaebacteria | Q39938412 | ||
| Clerocidin alkylates DNA through its epoxide function: evidence for a fine tuned mechanism of action. | Q39958978 | ||
| Cloning and mapping of the genetic determinants for microcin B17 production and immunity | Q39980792 | ||
| Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli | Q40087129 | ||
| Mechanism of inhibition of DNA gyrase by cyclothialidine, a novel DNA gyrase inhibitor | Q40286248 | ||
| Evidence for a conformational change in the DNA gyrase-DNA complex from hydroxyl radical footprinting | Q40399549 | ||
| Cyclothialidine and its congeners: a new class of DNA gyrase inhibitors | Q40667220 | ||
| The nature of inhibition of DNA gyrase by the coumarins and the cyclothialidines revealed by X-ray crystallography | Q41064279 | ||
| The peptide antibiotic microcin B17 induces double-strand cleavage of DNA mediated by E. coli DNA gyrase | Q41079914 | ||
| Simocyclinone D8, an inhibitor of DNA gyrase with a novel mode of action | Q41093787 | ||
| YacG from Escherichia coli is a specific endogenous inhibitor of DNA gyrase | Q41174909 | ||
| Control of cell division by sex factor F in Escherichia coli. II. Identification of genes for inhibitor protein and trigger protein on the 42.84-43.6 F segment | Q41547303 | ||
| Mechanism of action of the antibiotic NXL101, a novel nonfluoroquinolone inhibitor of bacterial type II topoisomerases | Q41925162 | ||
| Clerocidin selectively modifies the gyrase-DNA gate to induce irreversible and reversible DNA damage | Q42264322 | ||
| The high-resolution crystal structure of a 24-kDa gyrase B fragment from E. coli complexed with one of the most potent coumarin inhibitors, clorobiocin | Q42549663 | ||
| GyrI: a counter-defensive strategy against proteinaceous inhibitors of DNA gyrase | Q42724331 | ||
| Clerocidin interacts with the cleavage complex of Streptococcus pneumoniae topoisomerase IV to induce selective irreversible DNA damage | Q42872445 | ||
| Mapping simocyclinone D8 interaction with DNA gyrase: evidence for a new binding site on GyrB. | Q42947154 | ||
| The phytotoxin albicidin is a novel inhibitor of DNA gyrase. | Q42956928 | ||
| DNA gyrase from the albicidin producer Xanthomonas albilineans has multiple-antibiotic-resistance and unusual enzymatic properties | Q43111811 | ||
| 1,8-NAPHTHYRIDINE DERIVATIVES. A NEW CLASS OF CHEMOTHERAPEUTIC AGENTS. | Q43498212 | ||
| The antibiotic microcin B17 is a DNA gyrase poison: characterisation of the mode of inhibition | Q43567998 | ||
| ParE toxin encoded by the broad-host-range plasmid RK2 is an inhibitor of Escherichia coli gyrase | Q43993322 | ||
| Glycocinnamoylspermidines, a new class of antibiotics. II. Isolation, physiocochemical and biological properties of LL-BM123beta, gamma1 and gamma2. | Q44365753 | ||
| The action of the bacterial toxin microcin B17. Insight into the cleavage-religation reaction of DNA gyrase | Q44493496 | ||
| Chromosomally encoded gyrase inhibitor GyrI protects Escherichia coli against DNA-damaging agents | Q44589034 | ||
| Nucleotide binding to DNA gyrase causes loss of DNA wrap | Q44799104 | ||
| Evidence for the role of DNA strand passage in the mechanism of action of microcin B17 on DNA gyrase | Q46377091 | ||
| An open conformation of the Thermus thermophilus gyrase B ATP-binding domain | Q27637851 | ||
| Crystal structure of the Escherichia coli SbmC protein that protects cells from the DNA replication inhibitor microcin B17 | Q27638843 | ||
| DNA gyrase interaction with coumarin-based inhibitors: the role of the hydroxybenzoate isopentenyl moiety and the 5'-methyl group of the noviose | Q27639067 | ||
| NMR structure of the Escherichia coli protein YacG: a novel sequence motif in the zinc-finger family of proteins | Q27639582 | ||
| The solution structure of ParD, the antidote of the ParDE toxin-antitoxin module, provides the structural basis for DNA and toxin binding | Q27646891 | ||
| Structural insight into the quinolone-DNA cleavage complex of type IIA topoisomerases | Q27655501 | ||
| Crystal structure of DNA gyrase B' domain sheds lights on the mechanism for T-segment navigation | Q27656386 | ||
| Rejuvenation of CcdB-poisoned gyrase by an intrinsically disordered protein domain | Q27656829 | ||
| Crystal structure of the DNA gyrase GyrA N-terminal domain fromMycobacterium tuberculosis | Q27657595 | ||
| A crystal structure of the bifunctional antibiotic simocyclinone D8, bound to DNA gyrase | Q27658456 | ||
| A Conserved Mode of Protein Recognition and Binding in a ParD−ParE Toxin−Antitoxin Complex | Q27659672 | ||
| A domain insertion in Escherichia coli GyrB adopts a novel fold that plays a critical role in gyrase function | Q27663749 | ||
| Type IIA topoisomerase inhibition by a new class of antibacterial agents | Q27663884 | ||
| Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance | Q27664216 | ||
| Structural Insights into the Quinolone Resistance Mechanism of Mycobacterium tuberculosis DNA Gyrase | Q27664232 | ||
| Structure and mechanism of DNA topoisomerase II | Q27732221 | ||
| The entropic penalty of ordered water accounts for weaker binding of the antibiotic novobiocin to a resistant mutant of DNA gyrase: a thermodynamic and crystallographic study | Q27741104 | ||
| Crystal structure of the breakage-reunion domain of DNA gyrase | Q27742546 | ||
| Crystal structure of CcdB, a topoisomerase poison from E. coli | Q27766729 | ||
| The quinolones: decades of development and use | Q28191758 | ||
| The ATP-binding site of type II topoisomerases as a target for antibacterial drugs | Q28207771 | ||
| A common mechanism of cellular death induced by bactericidal antibiotics | Q28246128 | ||
| DNA topoisomerases and their poisoning by anticancer and antibacterial drugs | Q28284744 | ||
| Molecular mechanisms of drug inhibition of DNA gyrase | Q28287181 | ||
| Moonlighting function of glutamate racemase from Mycobacterium tuberculosis: racemization and DNA gyrase inhibition are two independent activities of the enzyme | Q28486911 | ||
| New antibacterial agents derived from the DNA gyrase inhibitor cyclothialidine | Q30909775 | ||
| Structural basis for nucleic acid and toxin recognition of the bacterial antitoxin CcdA. | Q31063061 | ||
| Cloning and analysis of the simocyclinone biosynthetic gene cluster of Streptomyces antibioticus Tü 6040. | Q31096529 | ||
| The action of the bacterial toxin, microcin B17, on DNA gyrase | Q33271871 | ||
| Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors | Q33339829 | ||
| Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase | Q33556397 | ||
| Interaction of the plasmid-encoded quinolone resistance protein QnrA with Escherichia coli topoisomerase IV | Q33883611 | ||
| New classification and update on the quinolone antibiotics | Q33902621 | ||
| At least two separate gene clusters are involved in albicidin production by Xanthomonas albilineans | Q36813442 | ||
| Energy coupling in type II topoisomerases: why do they hydrolyze ATP? | Q36854054 | ||
| Discovery and development of ATPase inhibitors of DNA gyrase as antibacterial agents | Q36907300 | ||
| In vivo and in vitro patterns of the activity of simocyclinone D8, an angucyclinone antibiotic from Streptomyces antibioticus | Q37190713 | ||
| Recent advances in bacterial topoisomerase inhibitors | Q37191811 | ||
| DNA topoisomerases: harnessing and constraining energy to govern chromosome topology | Q37255381 | ||
| Effects of magnesium and related divalent metal ions in topoisomerase structure and function. | Q37383911 | ||
| Quinolones: action and resistance updated | Q37595559 | ||
| DNA gyrase: subunit structure and ATPase activity of the purified enzyme | Q37596172 | ||
| The aminocoumarins: biosynthesis and biology. | Q37603068 | ||
| An unusual mechanism for resistance to the antibiotic coumermycin A1 | Q37603477 | ||
| DNA gyrase can cleave short DNA fragments in the presence of quinolone drugs | Q38344294 | ||
| A journey in the world of DNA rings and beyond | Q38571383 | ||
| A strand-passage conformation of DNA gyrase is required to allow the bacterial toxin, CcdB, to access its binding site | Q39079987 | ||
| The topoisomerase II poison clerocidin alkylates non-paired guanines of DNA: implications for irreversible stimulation of DNA cleavage | Q39229147 | ||
| Quinolone-binding pocket of DNA gyrase: role of GyrB. | Q39652111 | ||
| In the presence of subunit A inhibitors DNA gyrase cleaves DNA fragments as short as 20 bp at specific sites | Q39718939 | ||
| Active-site residues of Escherichia coli DNA gyrase required in coupling ATP hydrolysis to DNA supercoiling and amino acid substitutions leading to novobiocin resistance | Q39731838 | ||
| Mode of action of GR122222X, a novel inhibitor of bacterial DNA gyrase. | Q39781473 | ||
| GyrB mutations in Staphylococcus aureus strains resistant to cyclothialidine, coumermycin, and novobiocin. | Q39781947 | ||
| Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: selective targeting of gyrase or topoisomerase IV by quinolones. | Q39783715 | ||
| Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli | Q39816339 | ||
| Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones | Q48080383 | ||
| Control of segregation of chromosomal DNA by sex factor F in Escherichia coli. Mutants of DNA gyrase subunit A suppress letD (ccdB) product growth inhibition | Q48174226 | ||
| Simocyclinones, novel cytostatic angucyclinone antibiotics produced by Streptomyces antibioticus Tü 6040. I. Taxonomy, fermentation, isolation and biological activities | Q48744539 | ||
| Advances in structure-based drug design of novel bacterial topoisomerase inhibitors. | Q51720712 | ||
| Molecular basis of gyrase poisoning by the addiction toxin CcdB. | Q52287398 | ||
| Locking the DNA gate of DNA gyrase: investigating the effects on DNA cleavage and ATP hydrolysis. | Q53921739 | ||
| Probing the two-gate mechanism of DNA gyrase using cysteine cross-linking. | Q53923658 | ||
| Quinolone resistance from a transferable plasmid. | Q54143628 | ||
| Characterization of a cinodine-resistant mutant of Escherichia coli. | Q54158936 | ||
| The F plasmid CcdB protein induces efficient ATP-dependent DNA cleavage by gyrase. | Q54223810 | ||
| gyrB mutations which confer coumarin resistance also affect DNA supercoiling and ATP hydrolysis by Escherichia coli DNA gyrase. | Q54269895 | ||
| Total synthesis of microcin B17 via a fragment condensation approach. | Q54372116 | ||
| Simocyclinone D8 turns on against Gram-negative bacteria in a clinical setting. | Q54393558 | ||
| Preliminary characterization of an antibiotic produced by Xanthomonas albilineans which inhibits DNA synthesis in Escherichia coli. | Q54451458 | ||
| Small-angle X-ray scattering reveals the solution structure of the full-length DNA gyrase a subunit. | Q54491751 | ||
| Microcin B17 blocks DNA replication and induces the SOS system in Escherichia coli. | Q54784670 | ||
| The intrinsic ATPase of DNA gyrase | Q55062440 | ||
| Probing the Binding of Coumarins and Cyclothialidines to DNA Gyrase† | Q57980003 | ||
| The interaction of DNA gyrase with the bacterial toxin CcdB: evidence for the existence of two gyrase-CcdB complexes 1 1Edited by I. B. Holland | Q57980004 | ||
| Mass Spectrometry Reveals That the Antibiotic Simocyclinone D8 Binds to DNA Gyrase in a “Bent-Over” Conformation: Evidence of Positive Cooperativity in Binding | Q58299773 | ||
| Modular Structure of the Full-Length DNA Gyrase B Subunit Revealed by Small-Angle X-Ray Scattering | Q59694944 | ||
| The interaction of the F plasmid killer protein, CcdB, with DNA gyrase: induction of DNA cleavage and blocking of transcription 1 1J. Karn | Q59695031 | ||
| The 24 kDa N-terminal sub-domain of the DNA gyrase B protein binds coumarin drugs | Q59695062 | ||
| Clerocidin, a terpenoid antibiotic, inhibits bacterial DNA gyrase | Q59695072 | ||
| sbmC, a stationary-phase induced SOS Escherichia coli gene, whose product protects cells from the DNA replication inhibitor microcin B17 | Q64389506 | ||
| Type II DNA topoisomerases: enzymes that can unknot a topologically knotted DNA molecule via a reversible double-strand break | Q64390754 | ||
| Glycocinnamoylspermidines, a new class of antibiotics. I. Description and fermentation of the organism producing the LL-BM123 antibiotics | Q67355570 | ||
| The capture of a DNA double helix by an ATP-dependent protein clamp: a key step in DNA transport by type II DNA topoisomerases | Q67505712 | ||
| Induction of a heat-stable topoisomerase II-DNA cleavable complex by nonintercalative terpenoides, terpentecin and clerocidin | Q67916303 | ||
| The DNA replication inhibitor microcin B17 is a forty-three-amino-acid protein containing sixty percent glycine | Q68236075 | ||
| Characterization of the binding site for cyclothialidine on the B subunit of DNA gyrase | Q72315721 | ||
| DNA transport by a type II DNA topoisomerase: evidence in favor of a two-gate mechanism | Q72428717 | ||
| Microbial growth and production kinetics of Streptomyces antibioticus Tü 6040 | Q73956986 | ||
| Identification of DNA gyrase inhibitor (GyrI) in Escherichia coli | Q74088698 | ||
| Glycocinnamoylspermidines, a new class of antibiotics. II. Isolation, physicochemical and biological properties of LL-BM123.BETA.,.GAMMA.1 and .GAMMA.2. | Q78418871 | ||
| Peptides based on CcdB protein as novel inhibitors of bacterial topoisomerases | Q79665036 | ||
| Novel pyrazole derivatives as potent inhibitors of type II topoisomerases. Part 1: synthesis and preliminary SAR analysis | Q79973060 | ||
| Tetrahydroindazole inhibitors of bacterial type II topoisomerases. Part 2: SAR development and potency against multidrug-resistant strains | Q80028550 | ||
| The C-terminal domain of DNA gyrase A adopts a DNA-bending beta-pinwheel fold | Q33904609 | ||
| How antibiotics kill bacteria: from targets to networks | Q33958766 | ||
| Twisting of the DNA-binding surface by a beta-strand-bearing proline modulates DNA gyrase activity. | Q33959458 | ||
| Cell killing by the F plasmid CcdB protein involves poisoning of DNA-topoisomerase II complexes | Q33969008 | ||
| A fluoroquinolone resistance protein from Mycobacterium tuberculosis that mimics DNA. | Q33987554 | ||
| Mechanism of plasmid-mediated quinolone resistance | Q34025874 | ||
| The interaction of drugs with DNA gyrase: a model for the molecular basis of quinolone action | Q34092838 | ||
| Biosynthetic gene cluster of simocyclinone, a natural multihybrid antibiotic | Q34107244 | ||
| Quinolones: a comprehensive review | Q34115365 | ||
| Glutamate racemase is an endogenous DNA gyrase inhibitor | Q34147905 | ||
| Type II topoisomerases as targets for quinolone antibacterials: turning Dr. Jekyll into Mr. Hyde | Q34187326 | ||
| Differences in effects on DNA gyrase activity between two glutamate racemases of Bacillus subtilis, the poly-gamma-glutamate synthesis-linking Glr enzyme and the YrpC (MurI) isozyme | Q34209278 | ||
| Vibrio cholerae ParE2 poisons DNA gyrase via a mechanism distinct from other gyrase inhibitors | Q34401201 | ||
| Structural and biochemical analysis of the pentapeptide repeat protein EfsQnr, a potent DNA gyrase inhibitor | Q34483705 | ||
| Crystal structure of an N-terminal fragment of the DNA gyrase B protein. | Q34493198 | ||
| DNA gyrase: structure and function. | Q34507230 | ||
| Solution structures of DNA-bound gyrase | Q34513886 | ||
| Inhibition of DNA gyrase activity by Mycobacterium smegmatis MurI. | Q34733375 | ||
| Genetic engineering of antibiotic biosynthesis for the generation of new aminocoumarins. | Q34982610 | ||
| Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase | Q35042255 | ||
| Mechanism of action of nalidixic acid: Purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme | Q35059616 | ||
| Nalidixic acid resistance: A second genetic character involved in DNA gyrase activity | Q35059655 | ||
| Differential regulation of the mcb and emr operons of Escherichia coli: role of mcb in multidrug resistance. | Q35124032 | ||
| Catalytic topoisomerase II inhibitors in cancer therapy. | Q35187762 | ||
| Posttranslational modifications in microcin B17 define an additional class of DNA gyrase inhibitor | Q35238951 | ||
| Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli | Q35742369 | ||
| In vitro and in vivo activities of PD 0305970 and PD 0326448, new bacterial gyrase/topoisomerase inhibitors with potent antibacterial activities versus multidrug-resistant gram-positive and fastidious organism groups | Q35758905 | ||
| Energy coupling in DNA gyrase and the mechanism of action of novobiocin | Q35994466 | ||
| The export of the DNA replication inhibitor Microcin B17 provides immunity for the host cell | Q36064831 | ||
| gyrB mutations in coumermycin A1-resistant Borrelia burgdorferi | Q36107774 | ||
| Anti-proliferative effects of simocyclinone D8 (SD8), a novel catalytic inhibitor of topoisomerase II. | Q36136076 | ||
| A new family of low molecular weight antibiotics from enterobacteria | Q36500659 | ||
| Exploring DNA topoisomerases as targets of novel therapeutic agents in the treatment of infectious diseases | Q36754740 | ||
| Thirty years of Escherichia coli DNA gyrase: from in vivo function to single-molecule mechanism. | Q36775907 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mechanism of action | Q3271540 |
| DNA | Q7430 | ||
| bacteria | Q10876 | ||
| antibiotic | Q12187 | ||
| P304 | page(s) | 479-497 | |
| P577 | publication date | 2011-09-09 | |
| 2011-11-01 | |||
| P1433 | published in | Applied Microbiology and Biotechnology | Q13553694 |
| P1476 | title | Exploiting bacterial DNA gyrase as a drug target: current state and perspectives | |
| P478 | volume | 92 |
| Q27681978 | A New Crystal Structure of the Bifunctional Antibiotic Simocyclinone D8 Bound to DNA Gyrase Gives Fresh Insight into the Mechanism of Inhibition |
| Q37594988 | A Systematic Review of In vitro and In vivo Activities of Anti-Toxoplasma Drugs and Compounds (2006-2016). |
| Q52355825 | A new class of antibacterials, the imidazopyrazinones, reveal structural transitions involved in DNA gyrase poisoning and mechanisms of resistance. |
| Q48232919 | A rapid high-resolution method for resolving DNA topoisomers. |
| Q40696170 | Absorption, distribution, metabolism and elimination of 14C-ETX0914, a novel inhibitor of bacterial type-II topoisomerases in rodents |
| Q38061197 | Advances In Mycobacterium Tuberculosis Therapeutics Discovery Utlizing Structural Biology. |
| Q50117422 | Antibacterial Activities of Azole Complexes Combined with Silver Nanoparticles. |
| Q48260352 | Antibacterial Evaluation and Virtual Screening of New Thiazolyl-Triazole Schiff Bases as Potential DNA-Gyrase Inhibitors |
| Q52837803 | Antibacterial activity of enrofloxacin and ciprofloxacin derivatives of β-octaarginine. |
| Q89839118 | Antibacterial evaluation and molecular docking studies of pyrazole-thiosemicarbazones and their pyrazole-thiazolidinone conjugates |
| Q52661301 | Antimicrobial mechanism of resveratrol-trans-dihydrodimer produced from peroxidase-catalyzed oxidation of resveratrol. |
| Q64900346 | Antioxidant, Anti-Lung Cancer, and Anti-Bacterial Activities of Toxicodendron vernicifluum. |
| Q28486816 | Application of a novel microtitre plate-based assay for the discovery of new inhibitors of DNA gyrase and DNA topoisomerase VI |
| Q85280581 | Association of mutation patterns in GyrA and ParC genes with quinolone resistance levels in lactic acid bacteria |
| Q37998090 | Bacterial DNA replication enzymes as targets for antibacterial drug discovery |
| Q40203926 | Bifunctional antimicrobial conjugates and hybrid antimicrobials |
| Q42370986 | Binding of two DNA molecules by type II topoisomerases for decatenation |
| Q37335706 | Biological evaluation of benzothiazole ethyl urea inhibitors of bacterial type II topoisomerases |
| Q90256925 | Chemical classes targeting energy supplying GyrB domain of Mycobacterium tuberculosis |
| Q28547065 | Ciprofloxacin Derivatives Affect Parasite Cell Division and Increase the Survival of Mice Infected with Toxoplasma gondii |
| Q37218789 | Ciprofloxacin is an inhibitor of the Mcm2-7 replicative helicase |
| Q44887470 | Cluster-based molecular docking study for in silico identification of novel 6-fluoroquinolones as potential inhibitors against Mycobacterium tuberculosis. |
| Q91011800 | Cryo-EM structure of the complete E. coli DNA gyrase nucleoprotein complex |
| Q59791187 | CryoEM structures of open dimers of gyrase A in complex with DNA illuminate mechanism of strand passage |
| Q42004601 | DNA G-segment bending is not the sole determinant of topology simplification by type II DNA topoisomerases. |
| Q38377745 | DNA Gyrase Is the Target for the Quinolone Drug Ciprofloxacin in Arabidopsis thaliana. |
| Q91847145 | DNA Topoisomerase Inhibitors: Trapping a DNA-Cleaving Machine in Motion |
| Q49607722 | DNA Topoisomerases as Targets for Antibacterial Agents |
| Q92186488 | DNA gyrase could be a crucial regulatory factor for growth and survival of Mycobacterium leprae |
| Q39078552 | DNA replication proteins as potential targets for antimicrobials in drug-resistant bacterial pathogens. |
| Q58699156 | Deciphering intra-species bacterial diversity of meat and seafood spoilage microbiota using gyrB amplicon sequencing: A comparative analysis with 16S rDNA V3-V4 amplicon sequencing |
| Q48266288 | Design, Synthesis, and Evaluation of Novel Tyrosine-Based DNA Gyrase B Inhibitors. |
| Q42149617 | Determination of the primary molecular target of 1,2,4-triazole-ciprofloxacin hybrids. |
| Q57135855 | Development of Antibacterial and Antifungal Triazole Chromium(III) and Cobalt(II) Complexes: Synthesis and Biological Activity Evaluations |
| Q27684534 | Direct control of type IIA topoisomerase activity by a chromosomally encoded regulatory protein |
| Q35815665 | Discovery of Indazole Derivatives as a Novel Class of Bacterial Gyrase B Inhibitors |
| Q50982185 | Distinguishing on-target versus off-target activity in early antibacterial drug discovery using a macromolecular synthesis assay. |
| Q42364823 | Docking study, synthesis and antimicrobial evaluation of some novel 4-anilinoquinazoline derivatives. |
| Q41862904 | Draft Genome Sequence of Streptomyces niveus NCIMB 11891, Producer of the Aminocoumarin Antibiotic Novobiocin |
| Q41862909 | Draft Genome Sequence of Streptomyces roseochromogenes subsp. oscitans DS 12.976, Producer of the Aminocoumarin Antibiotic Clorobiocin |
| Q91266514 | Dual Escherichia coli DNA Gyrase A and B Inhibitors with Antibacterial Activity |
| Q64106397 | Effect of fractioning on antibacterial activity of n-butanol fraction from Enantia chlorantha stem bark methanol extract |
| Q40097660 | Enrofloxacin and Toltrazuril Are Able to Reduce Toxoplasma gondii Growth in Human BeWo Trophoblastic Cells and Villous Explants from Human Third Trimester Pregnancy |
| Q43473553 | Evaluation of WO2012177707 and WO2012097269: Vertex's phosphate prodrugs of gyrase and topoisomerase antibacterial agents |
| Q38408892 | Exploration of fluoroquinolone resistance in Streptococcus pyogenes: comparative structure analysis of wild-type and mutant DNA gyrase. |
| Q37380099 | Fluorescently labeled circular DNA molecules for DNA topology and topoisomerases. |
| Q28486124 | Fragments of the bacterial toxin microcin B17 as gyrase poisons |
| Q36100114 | Functional Analyses of the Toxoplasma gondii DNA Gyrase Holoenzyme: A Janus Topoisomerase with Supercoiling and Decatenation Abilities |
| Q41161517 | Genetic and chemical validation identifies Mycobacterium tuberculosis topoisomerase I as an attractive anti-tubercular target |
| Q90135947 | Genome mining reveals uncommon alkylpyrones as type III PKS products from myxobacteria |
| Q90455912 | Genome-wide assessment of antimicrobial tolerance in Yersinia pseudotuberculosis under ciprofloxacin stress |
| Q52628118 | Gut microbiota as a source of novel antimicrobials. |
| Q33797306 | Gyramides prevent bacterial growth by inhibiting DNA gyrase and altering chromosome topology |
| Q34057315 | High in vitro activity of the novel spiropyrimidinetrione AZD0914, a DNA gyrase inhibitor, against multidrug-resistant Neisseria gonorrhoeae isolates suggests a new effective option for oral treatment of gonorrhea |
| Q38980021 | History of Antibiotics Research |
| Q40529090 | Identification of 5,6-dihydroimidazo[2,1-b]thiazoles as a new class of antimicrobial agents. |
| Q93083428 | Identification of an auxiliary druggable pocket in the DNA gyrase ATPase domain using fragment probes |
| Q28828721 | Identification of novel bacterial DNA gyrase inhibitors: An in silico study |
| Q34821381 | Identification of the likely translational start of Mycobacterium tuberculosis GyrB. |
| Q92638354 | Identifying genetic determinants of complex phenotypes from whole genome sequence data |
| Q44147488 | In vitro and in vivo metabolism of 14C-AZ11, a novel inhibitor of bacterial DNA gyrase/type II topoisomerase |
| Q38761164 | In vitro biological evaluation of novel broad-spectrum isothiazolone inhibitors of bacterial type II topoisomerases. |
| Q92437903 | Indole hybridized diazenyl derivatives: synthesis, antimicrobial activity, cytotoxicity evaluation and docking studies |
| Q97549014 | Inhibition of indole production increases the activity of quinolone antibiotics against E. coli persisters |
| Q28550949 | Investigating the Roles of the C-Terminal Domain of Plasmodium falciparum GyrA |
| Q34375204 | Investigational antimicrobial agents of 2013. |
| Q36364221 | Isolation and quantitation of topoisomerase complexes accumulated on Escherichia coli chromosomal DNA. |
| Q94548290 | Lead Identification of 8-(Methylamino)-2-oxo-1,2-dihydroquinoline Derivatives as DNA Gyrase Inhibitors: Hit-to-Lead Generation Involving Thermodynamic Evaluation |
| Q35691408 | Mode of action of closthioamide: the first member of the polythioamide class of bacterial DNA gyrase inhibitors |
| Q58591045 | Modulation of S. aureus and P. aeruginosa biofilm: an in vitro study with new coumarin derivatives |
| Q38068475 | Multitarget ligands in antibacterial research: progress and opportunities |
| Q36619820 | Mycobacterium fluoroquinolone resistance protein B, a novel small GTPase, is involved in the regulation of DNA gyrase and drug resistance |
| Q37713025 | NBTI 5463 is a novel bacterial type II topoisomerase inhibitor with activity against gram-negative bacteria and in vivo efficacy |
| Q56423643 | NMR structural characterization of the N-terminal active domain of the gyrase B subunit fromPseudomonas aeruginosaand its complex with an inhibitor |
| Q78232525 | New Aminocoumarins from the Rare ActinomyceteCatenulispora acidiphilaDSM 44928: Identification, Structure Elucidation, and Heterologous Production |
| Q57265865 | New N-phenylpyrrolamide DNA gyrase B inhibitors: Optimization of efficacy and antibacterial activity |
| Q36153263 | New Structural Templates for Clinically Validated and Novel Targets in Antimicrobial Drug Research and Development. |
| Q48105075 | Novel Bacterial Topoisomerase Inhibitors Exploit Asp83 and the Intrinsic Flexibility of the DNA Gyrase Binding Site. |
| Q38949284 | Novel Bacterial Topoisomerase Inhibitors with Potent Broad-Spectrum Activity against Drug-Resistant Bacteria. |
| Q44049965 | Opposing effects of aminocoumarins and fluoroquinolones on the SOS response and adaptability in Staphylococcus aureus |
| Q36950824 | Optimization of a novel potent and selective bacterial DNA helicase inhibitor scaffold from a high throughput screening hit. |
| Q36365416 | Optimized droplet digital CFU assay (ddCFU) provides precise quantification of bacteria over a dynamic range of 6 logs and beyond |
| Q38645992 | Phenotypic and genetic heterogeneity within biofilms with particular emphasis on persistence and antimicrobial tolerance. |
| Q37658182 | Phytochemicals as Anticancer and Chemopreventive Topoisomerase II Poisons |
| Q92979830 | Polyhexamethylene Biguanide and Nadifloxacin Self-Assembled Nanoparticles: Antimicrobial Effects against Intracellular Methicillin-Resistant Staphylococcus aureus |
| Q92528876 | Potential Genes Related to Levofloxacin Resistance in Mycobacterium tuberculosis Based on Transcriptome and Methylome Overlap Analysis |
| Q36891270 | PprA Protein Is Involved in Chromosome Segregation via Its Physical and Functional Interaction with DNA Gyrase in Irradiated Deinococcus radiodurans Bacteria |
| Q58769267 | Predicting the evolution of Escherichia coli by a data-driven approach |
| Q28073043 | Protein/DNA interactions in complex DNA topologies: expect the unexpected |
| Q37497864 | Protein/DNA interactions in complex DNA topologies: expect the unexpected. |
| Q28548255 | Proteomics of Aggregatibacter actinomycetemcomitans Outer Membrane Vesicles |
| Q92999174 | Rapid Evolution of Reduced Susceptibility against a Balanced Dual-Targeting Antibiotic through Stepping-Stone Mutations |
| Q37012979 | Real-time detection of DNA topological changes with a fluorescently labeled cruciform. |
| Q36305708 | Residues of E. coli topoisomerase I conserved for interaction with a specific cytosine base to facilitate DNA cleavage |
| Q92753336 | Sea Bass Immunization to Downsize the Betanodavirus Protein Displayed in the Surface of Inactivated Repair-Less Bacteria |
| Q41518213 | SimC7 Is a Novel NAD(P)H-Dependent Ketoreductase Essential for the Antibiotic Activity of the DNA Gyrase Inhibitor Simocyclinone. |
| Q93177303 | Single-molecule imaging of DNA gyrase activity in living Escherichia coli |
| Q60359855 | Single-nucleotide-resolution mapping of DNA gyrase cleavage sites across the Escherichia coli genome. |
| Q90132296 | Spatial organization of RNA polymerase and its relationship with transcription in Escherichia coli |
| Q38262589 | Squaring up to DNA: pentapeptide repeat proteins and DNA mimicry |
| Q39210862 | Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action |
| Q46263843 | Structural insights into simocyclinone as an antibiotic, effector ligand, and substrate |
| Q58799715 | Structural insights into the gating of DNA passage by the topoisomerase II DNA-gate |
| Q49971305 | Structure elucidation and in silico docking studies of a novel furopyrimidine antibiotics synthesized by endolithic bacterium Actinomadura sp. AL2. |
| Q27679776 | Structure of an 'open' clamp type II topoisomerase-DNA complex provides a mechanism for DNA capture and transport |
| Q36394817 | Structure-based design of novel combinatorially generated NBTIs as potential DNA gyrase inhibitors against various Staphylococcus aureus mutant strains. |
| Q39401404 | Substrate-Assisted Catalysis in Polyketide Reduction Proceeds via a Phenolate Intermediate |
| Q47768932 | Synthesis and investigation of binding interactions of 1,4-benzoxazine derivatives on topoisomerase IV in Acinetobacter baumannii. |
| Q55422537 | Synthesis, antimicrobial evaluation and docking studies of some novel quinazolinone Schiff base derivatives. |
| Q28534970 | Synthesis, structure and antibacterial activity of potent DNA gyrase inhibitors: N'-benzoyl-3-(4-bromophenyl)-1H-pyrazole-5-carbohydrazide derivatives |
| Q35532866 | Targeting Mycobacterium tuberculosis topoisomerase I by small-molecule inhibitors |
| Q91581288 | The C7-aminomethylpyrrolidine group rescues the activity of a thio-fluoroquinolone |
| Q36999809 | The Chromosomal parDE2 Toxin-Antitoxin System of Mycobacterium tuberculosis H37Rv: Genetic and Functional Characterization |
| Q26752640 | The Current Case of Quinolones: Synthetic Approaches and Antibacterial Activity |
| Q37731253 | The Food Production Environment and the Development of Antimicrobial Resistance in Human Pathogens of Animal Origin |
| Q52656083 | The Macromolecular Machines that Duplicate the Escherichia coli Chromosome as Targets for Drug Discovery. |
| Q57291173 | The Multifaceted Antibacterial Mechanisms of the Pioneering Peptide Antibiotics Tyrocidine and Gramicidin S |
| Q36620880 | The naphthoquinone diospyrin is an inhibitor of DNA gyrase with a novel mechanism of action. |
| Q42408670 | The role of Ca²⁺ in the activity of Mycobacterium tuberculosis DNA gyrase. |
| Q39338697 | The role of monovalent cations in the ATPase reaction of DNA gyrase |
| Q33782498 | Thiophene antibacterials that allosterically stabilize DNA-cleavage complexes with DNA gyrase |
| Q34948044 | Time- and cost-efficient identification of T-DNA insertion sites through targeted genomic sequencing |
| Q49832269 | Topoisomerases as anticancer targets |
| Q38968355 | Topoisomerases: Resistance versus Sensitivity, How Far We Can Go? |
| Q28538627 | Toward discovering new anti-cancer agents targeting topoisomerase IIα: a facile screening strategy adaptable to high throughput platform |
| Q28538023 | Tricyclic GyrB/ParE (TriBE) inhibitors: a new class of broad-spectrum dual-targeting antibacterial agents |
| Q35530176 | Unique features of apicoplast DNA gyrases from Toxoplasma gondii and Plasmodium falciparum |
| Q41991537 | Versatility of 7-Substituted Coumarin Molecules as Antimycobacterial Agents, Neuronal Enzyme Inhibitors and Neuroprotective Agents. |
| Q55227172 | Why Two? On the Role of (A-)Symmetry in Negative Supercoiling of DNA by Gyrase. |
| Q38751212 | YcaO-Dependent Posttranslational Amide Activation: Biosynthesis, Structure, and Function |
Search more.